SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-23-120129
Filing Date
2023-04-27
Accepted
2023-04-27 08:00:27
Documents
7
Period of Report
2023-06-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A d457358ddef14a.htm DEF 14A 321064
2 GRAPHIC g457358g00s38.jpg GRAPHIC 119977
3 GRAPHIC g457358g00s39.jpg GRAPHIC 236391
4 GRAPHIC g457358g03l16.jpg GRAPHIC 26948
5 GRAPHIC g457358g05a44.jpg GRAPHIC 36380
6 GRAPHIC g457358g05b20.jpg GRAPHIC 29277
7 GRAPHIC g457358g12r13.jpg GRAPHIC 20949
  Complete submission text file 0001193125-23-120129.txt   943889
Mailing Address 45 LIBERTY BLVD. SUITE 230 MALVERN PA 19355
Business Address 45 LIBERTY BLVD. SUITE 230 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Filer) CIK: 0001563577 (see all company filings)

IRS No.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39114 | Film No.: 23851997
SIC: 2834 Pharmaceutical Preparations